Also, it has been reported that miR-452could directly target WWP1 in prostate cancer cells [31], which partially supported our results that miR-15b could target and negatively regulate WWP1 to promote osteogenic differentiation of hBMSCs. Here, WWP1 is linked to prostate carcinoma.